zalcitabine has been researched along with Leukemia P388 in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hua, M; Vince, R | 1 |
Kawaguchi, T; Kimura, S; Sakairi, H; Saneyoshi, M; Yamaguchi, T | 1 |
Kawaguchi, T; Saneyoshi, M; Shudo, K; Tomikawa, A; Yamaguchi, T | 1 |
Balzarini, J; Broder, S; Cooney, DA; Dalal, M; Johns, DG; McMahon, JB; Mitsuya, H; Nadkarni, M | 1 |
4 other study(ies) available for zalcitabine and Leukemia P388
Article | Year |
---|---|
Synthesis and anti-HIV activity of carbocyclic 2',3'-didehydro-2',3'-dideoxy 2,6-disubstituted purine nucleosides.
Topics: Animals; Antiviral Agents; Chemical Phenomena; Chemistry; Cytopathogenic Effect, Viral; Dideoxyadenosine; Dideoxynucleosides; HIV; Leukemia P388; Molecular Structure; Purine Nucleosides; Structure-Activity Relationship; Tumor Cells, Cultured; Virus Replication; Zidovudine | 1990 |
Synthesis and antileukemic activity of chymotrypsin-activated derivatives of 3'-amino-2',3'-dideoxycytidine. (Synthetic nucleosides and nucleotides. XXXIII.
Topics: Animals; Antineoplastic Agents; Biotransformation; Chymotrypsin; Deoxycytosine Nucleotides; Leukemia P388; Mice; Zalcitabine | 1995 |
Chiral influences of feedback inhibition with dCTP on murine deoxycytidine kinase.
Topics: Adenosine Triphosphate; Animals; Deoxycytidine; Deoxycytidine Kinase; Deoxycytosine Nucleotides; Feedback; Humans; Kinetics; Leukemia P388; Mice; Stereoisomerism; Substrate Specificity; Zalcitabine | 1997 |
Initial studies on the cellular pharmacology of 2',3-dideoxycytidine, an inhibitor of HTLV-III infectivity.
Topics: Animals; Cell Line; Chromatography, High Pressure Liquid; Cytopathogenic Effect, Viral; Deltaretrovirus; Deoxycytidine; Deoxycytidine Kinase; Female; Goats; Humans; Leukemia P388; Mice; Structure-Activity Relationship; Thioinosine; Zalcitabine | 1986 |